Medy-Tox Inc. (KOSDAQ:086900)
69,200
-3,800 (-5.21%)
Nov 20, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 446.91 billion as of November 20, 2026. It is the 16,583rd most valuable company in the world and the 443rd biggest in South Korea. Its market cap has decreased by 47.82% in one year.
Market Cap
446.91B
Enterprise Value
528.46B
Revenue
251.08B
Global Rank
Country Rank
#443 South Korea
PE Ratio
30.92
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 446.91B, an increase of 523.09%. That is a compound annual growth rate of 10.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 446.91B | -47.30% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 676.19B |
| Proteina | 645.56B |
| Komipharm International | 598.76B |
| Hyundai Bioscience | 585.78B |
| Pharmicell | 469.23B |
| AbClon | 465.88B |
| Onconic Therapeutics | 463.61B |
| GI Innovation | 427.10B |